Researchers from Johns Hopkins University have developed an oral treatment that could soon be used to destroy cancer cells ...
Just a few months after Boehringer Ingelheim broke into the oncology space with the first drug that can target a rare tumor ...
Immunotherapy, which harnesses our body's own immune system to fight cancer, has revolutionized modern oncology. Yet despite ...
Tumor infiltrating lymphocyte (TIL) therapy uses immune cells harvested directly from a patient’s tumor.
Despite the success of immune checkpoint inhibitors in revolutionizing oncology, their benefits remain limited to a small ...
A new report says too few eligible Americans are being checked for the country’s deadliest cancer before it spreads.
New Clinical Trial Site Added for Clinical Studies of Reqorsa® Gene Therapy to Treat Lung Cancer Acclaim-1 and Acclaim-3 Clinical Trials Supported by FDA Fast Track ...
Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free ...
Summit Therapeutics' Ivonescimab targets non-small cell lung cancer through its dual anti-PD-1 plus anti-VEGF mechanism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback